Published on 11/06/2026

Establishing Effective Pharmacovigilance Governance Under Revised Schedule M

Introduction to PV Governance in Indian Pharma

Pharmacovigilance (PV) governance is a critical aspect of pharmaceutical compliance under Revised Schedule M. It ensures that the safety of medicinal products is continuously monitored, and any adverse drug reactions (ADRs) are reported and managed effectively. Establishing a robust PV governance framework involves the roles of Qualified Person for Pharmacovigilance (QPPV) and the Pharmacovigilance System Master File (PSMF).

Understanding the Role of QPPV

The QPPV is responsible for overseeing the PV system and ensuring compliance with regulatory requirements. This role includes:

• Monitoring and evaluating ADRs.
• Ensuring timely reporting to the Central Drugs Standard Control Organization (CDSCO).
• Implementing corrective actions and preventive measures (CAPA) when necessary.

Establishing the Pharmacovigilance System Master File (PSMF)

The PSMF is a critical document that outlines the PV system’s structure and processes. It should include:

• Details of the QPPV and their contact information.
• Processes for ADR collection, assessment, and reporting.
• Documentation of training programs for staff involved in PV activities.

Implementing Standard Operating Procedures (SOPs)

To ensure compliance and readiness for CDSCO inspections, it is essential to establish clear SOPs. These should cover:

• ADR reporting mechanisms.
• Data management and documentation practices.
• Roles and responsibilities of personnel involved in PV.

Documentation and Inspection Readiness

Documentation is a cornerstone of PV governance. Maintaining accurate and comprehensive records will facilitate inspection readiness. Key documentation practices include:

• Regular updates to the PSMF.
• Maintaining logs of ADR reports and follow-ups.
• Documenting training sessions and outcomes.

Integrating Quality Assurance (QA) with PV Governance

Integrating QA processes with PV governance enhances compliance and safety. This can be achieved by:

• Conducting regular audits of PV processes.
• Implementing feedback mechanisms for continuous improvement.
• Ensuring that QA personnel are involved in PV training and development.

Training and Continuous Improvement

Regular training for all stakeholders involved in pharmacovigilance is essential. This includes:

• Updates on regulatory changes and best practices.
• Workshops on effective ADR reporting.
• Simulations of inspection scenarios to prepare staff.

FAQs

1. What is the role of the QPPV in pharmacovigilance?

The QPPV oversees the pharmacovigilance system, ensuring compliance with regulations and managing ADR reporting and assessments.

2. What should be included in the PSMF?

The PSMF should include details about the QPPV, ADR reporting processes, and documentation of training programs.

3. How can SOPs improve pharmacovigilance compliance?

SOPs provide clear guidelines for ADR reporting and documentation, ensuring consistency and compliance during inspections.

4. Why is documentation important for CDSCO inspections?

Comprehensive documentation demonstrates compliance with regulations and facilitates a smoother inspection process.

5. How can QA integration enhance pharmacovigilance?

QA integration ensures that PV processes are regularly audited and improved, leading to better compliance and safety outcomes.

Related Resources

For more information on pharmacovigilance compliance under Revised Schedule M, visit our Pillar Page on Schedule M Pharmacovigilance Compliance.